Logo image of BFLY

BUTTERFLY NETWORK INC (BFLY) Stock Fundamental Analysis

NYSE:BFLY - New York Stock Exchange, Inc. - US1241551027 - Common Stock - Currency: USD

4.43  -0.28 (-5.94%)

After market: 4.47 +0.04 (+0.9%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BFLY. BFLY was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While BFLY has a great health rating, there are worries on its profitability. BFLY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BFLY has reported negative net income.
BFLY had a negative operating cash flow in the past year.
In the past 5 years BFLY always reported negative net income.
BFLY had a negative operating cash flow in each of the past 5 years.
BFLY Yearly Net Income VS EBIT VS OCF VS FCFBFLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

The Return On Assets of BFLY (-37.14%) is worse than 60.11% of its industry peers.
BFLY has a Return On Equity (-54.18%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -37.14%
ROE -54.18%
ROIC N/A
ROA(3y)-30%
ROA(5y)N/A
ROE(3y)-39.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BFLY Yearly ROA, ROE, ROICBFLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

With a Gross Margin value of 29.60%, BFLY is not doing good in the industry: 76.60% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for BFLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BFLY Yearly Profit, Operating, Gross MarginsBFLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200 -300

8

2. Health

2.1 Basic Checks

BFLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BFLY has been increased compared to 1 year ago.
There is no outstanding debt for BFLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BFLY Yearly Shares OutstandingBFLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M 200M
BFLY Yearly Total Debt VS Total AssetsBFLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.59 indicates that BFLY is not in any danger for bankruptcy at the moment.
BFLY's Altman-Z score of 3.59 is fine compared to the rest of the industry. BFLY outperforms 71.28% of its industry peers.
There is no outstanding debt for BFLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.59
ROIC/WACCN/A
WACC9.17%
BFLY Yearly LT Debt VS Equity VS FCFBFLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 4.66 indicates that BFLY has no problem at all paying its short term obligations.
The Current ratio of BFLY (4.66) is better than 75.53% of its industry peers.
A Quick Ratio of 2.95 indicates that BFLY has no problem at all paying its short term obligations.
The Quick ratio of BFLY (2.95) is better than 64.36% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 2.95
BFLY Yearly Current Assets VS Current LiabilitesBFLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.59% over the past year.
BFLY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.48%.
EPS 1Y (TTM)24.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.46%
Revenue 1Y (TTM)11.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.33%

3.2 Future

Based on estimates for the next years, BFLY will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.25% on average per year.
Based on estimates for the next years, BFLY will show a very strong growth in Revenue. The Revenue will grow by 24.63% on average per year.
EPS Next Y45.6%
EPS Next 2Y22.6%
EPS Next 3Y16.25%
EPS Next 5YN/A
Revenue Next Year26.26%
Revenue Next 2Y22.96%
Revenue Next 3Y24.63%
Revenue Next 5YN/A

3.3 Evolution

BFLY Yearly Revenue VS EstimatesBFLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BFLY Yearly EPS VS EstimatesBFLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8

0

4. Valuation

4.1 Price/Earnings Ratio

BFLY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BFLY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFLY Price Earnings VS Forward Price EarningsBFLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFLY Per share dataBFLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as BFLY's earnings are expected to grow with 16.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.6%
EPS Next 3Y16.25%

0

5. Dividend

5.1 Amount

BFLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BUTTERFLY NETWORK INC

NYSE:BFLY (2/20/2025, 8:04:01 PM)

After market: 4.47 +0.04 (+0.9%)

4.43

-0.28 (-5.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-01 2024-11-01/bmo
Earnings (Next)03-04 2025-03-04/amc
Inst Owners30.67%
Inst Owner Change23.14%
Ins Owners8.63%
Ins Owner Change5.82%
Market Cap1.05B
Analysts84.44
Price Target4.93 (11.29%)
Short Float %8.35%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.44%
Min EPS beat(2)9.51%
Max EPS beat(2)31.37%
EPS beat(4)3
Avg EPS beat(4)1.67%
Min EPS beat(4)-52.51%
Max EPS beat(4)31.37%
EPS beat(8)7
Avg EPS beat(8)9.78%
EPS beat(12)10
Avg EPS beat(12)15.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)6.06%
Max Revenue beat(2)7.59%
Revenue beat(4)4
Avg Revenue beat(4)5.54%
Min Revenue beat(4)3.03%
Max Revenue beat(4)7.59%
Revenue beat(8)5
Avg Revenue beat(8)1.51%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)48.72%
PT rev (3m)61.11%
EPS NQ rev (1m)-11.54%
EPS NQ rev (3m)-11.54%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)4.55%
Revenue NQ rev (3m)4.55%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.77
P/FCF N/A
P/OCF N/A
P/B 5.77
P/tB 6.08
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.32
BVpS0.77
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE -54.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.6%
FCFM N/A
ROA(3y)-30%
ROA(5y)N/A
ROE(3y)-39.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 47.61%
Cap/Sales 6.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.66
Quick Ratio 2.95
Altman-Z 3.59
F-Score3
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)246.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)15.43%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.46%
EPS Next Y45.6%
EPS Next 2Y22.6%
EPS Next 3Y16.25%
EPS Next 5YN/A
Revenue 1Y (TTM)11.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.33%
Revenue Next Year26.26%
Revenue Next 2Y22.96%
Revenue Next 3Y24.63%
Revenue Next 5YN/A
EBIT growth 1Y29.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.62%
EBIT Next 3Y23.81%
EBIT Next 5YN/A
FCF growth 1Y72.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.76%
OCF growth 3YN/A
OCF growth 5YN/A